Bocom initiated coverage of AstraZeneca with a Buy rating and $93.30 price target.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- Legend Biotech an attractive takeover target for biopharma, says Daiwa
- AstraZeneca completes acquisition of Amolyt Pharma
- Is AstraZeneca Stock (NASDAQ:AZN) Overbought or Worth the Valuation?
- AstraZeneca price target lowered to 13,100 GBp from 13,400 GBp at Guggenheim
- AstraZeneca price target raised to 14,000 GBp from 13,500 GBp at Barclays